Company profile

Burning Point Medical company profile

Burning Point Medical develops pharmaceutical products for hypertensive and spastic pain disorders. Burning Point's products aim to treat hypertension, and relieve chest pain and spastic pains, enabling healthcare professionals to prescribe more effective treatments to their patients.

Business identity

Operating status
Active
Company type
For Profit
Founded
2019-01-01

Headquarters

Headquarters
Ning’er, Yunnan, China
Country code
CN
Continent
Asia

Capital profile

Funding and company signals

Funding stage
Late Stage Venture
Funding rounds
2
Total equity funding
$6.9M
Last funding
Series C / $6.9M / 2025-04-18
Last equity funding
Series C / $6.9M
Investors
3
Lead investors
2

Founders and investors

Lead investors

Guohai Innovative CCI CapitalHunan Jiudian Pharmaceutical

Investors

BGI Co-WinGuohai Innovative CCI CapitalHunan Jiudian Pharmaceutical

People at this company

Preview only. Contact details are available after you sign in.

Log in to view people and contact details at this company

Contact information and company affiliations may no longer be accurate. Verify details before reaching out.

Shipment data

Explore detailed shipment data

Sign in to view shipment history, products, suppliers, and trade lanes for this company.

Log in to view shipment data

Shipment records and coverage can change as the dataset is updated.